Defining opioid dosages | New hope for Glioblastoma patients
Genetic markers in movement disorders
CINCINNATI, OH–Movement disorders include a range of conditions affecting the nervous system, with more rare disorders increasingly found to be caused by genetic mutations. University of Cincinnati researchers are expanding a study to learn more about the genetic markers of these movement disorders.
Technology that can prevent patient falls
PEORIA, IL–VirtuSense Technologies, which has developed AI-powered sensor technology that detects and prevents patient falls before they occur, has been named to Fast Company’s prestigious annual list of the World’s Most Innovative Companies for 2022. Fast Company’s editors and writers sought out the most groundbreaking businesses across the globe and industries.
Type 2 diabetes and vascular health
BLOOMINGTON, IN–Researchers at Indiana University School of Medicine, in collaboration with the University of Alabama at Birmingham and five other institutions, are investigating novel regenerative medicine approaches to better manage vascular health complications from type 2 diabetes. The research could someday support blood vessel repair in the eye among diabetic patients with early retinal vascular dysfunction.
New hope for glioblastoma patients
ANN ARBOR, MI–More research news from Michigan. A new clinical trial from a team at the University of Michigan Rogel Cancer Center uses innovative basic science research methods to offer hope and a new treatment to glioblastoma patients. Glioblastoma is an aggressive brain tumor that’s largely resistant to current treatment, almost always recurs, and comes with a grim prognosis. The team has discovered that purines, the metabolites that are the building blocks of DNA, were really, really high in brain tumors that were most resistant to radiation.